Developing Products  In Pursuit Of Enhanced Clinical Outcomes With Novel Bioactive Materials

To stay on the cutting edge of spinal innovation, CES reinvests a substantial percentage of it’s annual revenues back into the research and development of new innovative technologies. It is a long-term commitment; one of our guiding principles.

CES’s objective is to develop every year, in partnership with surgeons and strategic partners, outstanding new spinal technologies that are not only clinically relevant but are also game changers within the spine industry.

Our management team believes that this strategy will keep CES ahead of it’s competition and create extreme value.

We are in the process of establishing Centers of Excellence for our Research and Development projects. In each of these Centers of Excellence, CES researchers work continuously to develop the spinal technologies of tomorrow.

Having a ‘patient first’ mentality and abiding by extreme ethics relative to Surgeon relationships is at the core of our organic development initiatives.

request more information

why Cutting Edge Spine

CES provides the spine marketplace with an unparalleled skill set – from product design, regulatory affairs, and bio-mechanical engineering, through customer care and supply chain management.

our portfolio includes

  • EVOL®SI Joint Fusion System
  • EVOSha Lumbar Interbody System
  • EVOL®ha-C Cervical Interbody System
  • nuMIS™ semi-rigid  lumbar plating system

This technology improves osseointegration through the combination of high wettability and optimal surface chemistry (with optimized nano-roughness) that mediates bioactivity and specific protein adsorption to the implant.

Invibio™ Biomaterial Solutions’ PEEK-OPTIMA® HA Enhanced is a material enhancement in spinal device technology. Hydroxyapatite (HA), a well-known osteoconductive material, is fully integrated with PEEK-OPTIMA® Natural, making it available on all surfaces of a device.

EVOSha is the first HA enhanced PEEK Lumbar Interbody system to be FDA cleared (i.e. 510k) in the United States.

Coming Soon

Take a look at our implant systems in development. *these products are not 510(k) cleared for sale in the United States.